Global Blood Therapeutics, Inc.
GBT · NASDAQ
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$303,091 | -$247,553 | -$266,766 | -$174,193 |
| Dep. & Amort. | $8,616 | $10,823 | $9,932 | $4,607 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $78,670 | $71,477 | $45,651 | $30,080 |
| Change in WC | -$42,436 | -$47,267 | $27,081 | $4,747 |
| Other Non-Cash | $1,428 | $658 | -$10,315 | -$616 |
| Operating Cash Flow | -$256,813 | -$211,862 | -$194,417 | -$135,375 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$3,233 | -$8,754 | -$3,460 | -$4,824 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$50,353 | -$57,936 | -$434,919 | -$361,405 |
| Inv. Sales/Matur. | $65,696 | $384,002 | $361,473 | $181,997 |
| Other Inv. Act. | $0 | $0 | $45 | $75 |
| Investing Cash Flow | $12,110 | $317,312 | -$76,861 | -$184,157 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $46,143 | $0 | $219,443 | $396,501 |
| Stock Repurch. | $0 | $0 | $0 | -$12 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $434,335 | $87,120 | $298,158 | $397,906 |
| Financing Cash Flow | $434,335 | $87,120 | $298,158 | $397,906 |
| Forex Effect | $319 | $0 | $0 | $0 |
| Net Chg. in Cash | $189,951 | $192,570 | $26,880 | $78,374 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $497,202 | $304,632 | $277,752 | $199,378 |
| End Cash | $687,153 | $497,202 | $304,632 | $277,752 |
| Free Cash Flow | -$260,046 | -$220,616 | -$197,877 | -$140,199 |